Aug 2026Sagimet advances Phase 3 trial of denifanstat toward enrollmentClinical Aug 2026Zepto Life awarded up to $8.9M NIAID contract for liquid biopsy platformFinancing Jun 2026MultiValent launches with $27 Million Series A FinancingNewCo & Financing Mar 2026Minnesota Medical Technologies secures $20M Series AFinancing Mar 2026Airiver Medical granted FDA Breakthrough Device DesignationRegulatory Feb 2026Sobi completes acquisition of Arthrosi TherapeuticsM&A Jan 2026OncoC4 Receive FDA Orphan Drug Designation for GotistobartRegulatory Dec 2025Sobi to acquire Arthrosi Therapeutics for the potential treatment of goutM&A Dec 2025Airiver Secures IDE Pivotal Study for Patients with Chronic RhinosinusitisRegulatory Dec 2025OncoC4 Announces Benefit in Squamous Non-Small Cell Lung CancerClinical Oct 2025Arthrosi Secures $153 Million in Series E FinancingFinancing Oct 2025OncoC4 Closes Nearly $50 Million in Series B FinancingFinancing Sept 2025GenFleet Therapeutics (2595.HK) Completes Initial Public Offering on HKEXIPO Aug 2025Airiver Receives IDE Approval for Treating Benign Central Airway StenosisRegulatory Aug 2025Arthrosi Achieves Full Enrollment of the Second Pivotal Phase 3 TrialClinical Jul 2025Minnesota Medical Technologies Announces FDA 510(k) ClearanceRegulatory May 2025UC Davis Partners with Global Venture Capital FirmPartnership Aug 2024Melodi Announces Series A Funding and First Enrollment in Pivotal Clinical TrialFinancing & Clinical Jun 2024Osteal Therapeutics closes 50 Million Series D Financing led by Zimmer BiometFinancing May 2024Harry Hoffman and David Herbert join the HM Venture Partners teamPersonnel Jan 2024Sagimet Biosciences Announces Positive Results from Phase 2b Clinical TrialClinical Dec 2023Osteal Receives FDA's Breakthrough Therapy DesignationRegulatory Oct 2023Novo Nordisk Buys Hypertension Company, KBP, in $1.3 Billion DealM&A Sept 2023Osteal Therapeutics Closes $23M Series C FinancingFinancing Sept 2023Laborie to Acquire Urotronic BPH product for up to $600 MillionM&A July 2025Urotronic Announces FDA Approval of BPH Catheter SystemRegulatory Mar 2023BioNTech and OncoC4 Announce Strategic CollaborationPartnership Dec 2022GIE Medical Launches Two Clinical Pivotal TrialsClinical Nov 2022Osteal Completes Enrollment in APEX Phase 2 Clinical TrialClinical Nov 2022Sagimet Biosciences Announces Positive Interim Phase 2b Clinical Trial DataClinical Jan 2022Laborie to Acquire Urotronic Urethral Stricture productM&A Dec 2021Urotronic Receives FDA Approval for Urethral Stricture ProductRegulatory Nov 2020Merck to Acquire OncoImmuneM&A Jan 2015Mayo Clinic Signs Joint Venture Agreement with Hillhouse Capital GroupNewCo